Kephalis (CAS 36306-87-3) has emerged as a critical component in the API intermediates market, specifically for the synthesis of complex pharmaceutical molecules and as a specialized reagent in medicinal chemistry. As a bulk chemical supplier, we are seeing a significant shift where CDMOs are increasing their demand fo...